Trade this ETF at your broker
Fund size | EUR 741 m |
Total expense ratio | 0.12% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in EUR) | 12.05% |
Inception/ Listing Date | 12 September 2017 |
Distribution policy | Distributing |
Distribution frequency | Annually |
Fund domicile | Ireland |
Fund Provider | Xtrackers |
Fund Structure | Company With Variable Capital (SICAV) |
UCITS compliance | Yes |
Administrator | State Street Custodial Services (Ireland) Limited |
Investment Advisor | DWS Investments UK Ltd |
Custodian Bank | State Street Custodial Services (Ireland) Limited |
Revision Company | Pricewaterhouse Coopers |
Fiscal Year End | 31 December |
Swiss representative | DWS CH AG |
Swiss paying agent | Deutsche Bank (Suisse) SA |
Tax data | Bundesanzeiger | |
Germany | 30% tax rebate | |
Switzerland | ESTV Reporting | |
Austria | Tax Reporting Fund | |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | |
Securities lending | Yes |
Securities lending counterparty |
Eli Lilly & Co | 10.97% |
UnitedHealth Group | 8.29% |
Johnson & Johnson | 6.98% |
Merck & Co | 5.84% |
AbbVie | 5.64% |
Thermo Fisher Scientific | 3.96% |
Abbott Laboratories | 3.74% |
Danaher | 3.22% |
Pfizer | 2.74% |
Amgen | 2.66% |
United States | 96.44% |
Ireland | 2.54% |
Other | 1.02% |
Health Care | 98.98% |
Other | 1.02% |
Broker | Rating | Savings plan offer | Brokerage fee | More information |
---|---|---|---|---|
free of charge | free of charge | More info | ||
free of charge | free of charge | More info | ||
free of charge | free of charge | More info | ||
free of charge | free of charge | More info | ||
free of charge | free of charge | More info |
YTD | +5.53% |
1 month | -3.25% |
3 months | +1.72% |
6 months | +7.38% |
1 year | +7.39% |
3 years | +32.54% |
5 years | +83.43% |
Since inception (MAX) | +104.88% |
2023 | -1.64% |
2022 | +2.98% |
2021 | +35.25% |
2020 | +4.95% |
Current dividend yield | 1.22% |
Dividends (last 12 months) | EUR 0.64 |
Period | Dividend in EUR | Dividend yield in % |
---|---|---|
1 Year | EUR 0.64 | 1.29% |
2023 | EUR 0.61 | 1.19% |
2022 | EUR 0.84 | 1.65% |
2021 | EUR 0.42 | 1.10% |
2020 | EUR 0.42 | 1.16% |
Volatility 1 year | 12.05% |
Volatility 3 years | 16.22% |
Volatility 5 years | 19.64% |
Return per risk 1 year | 0.61 |
Return per risk 3 years | 0.61 |
Return per risk 5 years | 0.66 |
Maximum drawdown 1 year | -6.34% |
Maximum drawdown 3 years | -13.82% |
Maximum drawdown 5 years | -27.86% |
Maximum drawdown since inception | -27.86% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | XUHC | - - | - - | - |
Stuttgart Stock Exchange | EUR | XUHC | - - | - - | - |
London Stock Exchange | GBX | XSHC | XSHC LN XUHCEUIV | XSHC.L XUHCEURINAV=SOLA | |
London Stock Exchange | USD | XUHC | XUHC LN XUHCUSIV | XUHC.L XUHCUSDINAV=SOLA | |
SIX Swiss Exchange | USD | XUHC | XUHC SW XSHCGBIV | XUHC.S XSHCINAV=SOLA | |
SIX Swiss Exchange | CHF | XUHC | XUHC SW XSHCGBIV | XUHC.S XSHCINAV=SOLA | |
XETRA | EUR | XUHC | XUHC GY | XUHC.DE |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares S&P 500 Health Care Sector UCITS ETF (Acc) | 1,935 | 0.15% p.a. | Accumulating | Full replication |
Invesco Nasdaq Biotech UCITS ETF | 564 | 0.40% p.a. | Accumulating | Swap-based |
iShares Nasdaq US Biotechnology UCITS ETF | 418 | 0.35% p.a. | Accumulating | Sampling |
SPDR S&P US Health Care Select Sector UCITS ETF | 351 | 0.15% p.a. | Accumulating | Full replication |
Invesco US Health Care Sector UCITS ETF | 290 | 0.14% p.a. | Accumulating | Swap-based |